MediMabBio
Business Services · 11-50 Employees
View Company Info for Free
Overview
Phone Number
+44 2074607899Website
www.medimabbio.netRevenue
<$5 MillionIndustry
About MediMabBio
Our discovery platform uses advances in systems biology combined with sophisticated immunological solutions to identify significantly improved first-in-class immuno-oncology drugs that can actively target a range of advanced and solid tumors. The company has developed pipelines of highly promising novel drugs that aim to overcome the current limitations of cancer immunotherapy. For this purpose, MediMabBio has established collaborations with core partners of academic, R&D institutions and clinical groups in US, UK, Germany, China and Korea. ResearchExplore more
MediMabBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to MediMabBio
Compare insights from companies similar to MediMabBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
MediMabBio Tech Stack
A closer look at the technologies used by MediMabBio
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MediMabBio
Sign Up For FreeTo access detailed company insights
Our discovery platform uses advances in systems biology combined with sophisticated immunological solutions to identify significantly improved first-in-class immuno-oncology drugs that can actively target a range of advanced and solid tumors. The company has developed pipelines of highly promising novel drugs that aim to overcome the current limita... Read More
